T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more
T&L Co. Ltd (340570) - Net Assets
Latest net assets as of September 2025: ₩199.09 Billion KRW
Based on the latest financial reports, T&L Co. Ltd (340570) has net assets worth ₩199.09 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩219.17 Billion) and total liabilities (₩20.08 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩199.09 Billion |
| % of Total Assets | 90.84% |
| Annual Growth Rate | 32.62% |
| 5-Year Change | 138.27% |
| 10-Year Change | N/A |
| Growth Volatility | 33.36 |
T&L Co. Ltd - Net Assets Trend (2017–2024)
This chart illustrates how T&L Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for T&L Co. Ltd (2017–2024)
The table below shows the annual net assets of T&L Co. Ltd from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩171.44 Billion | +32.33% |
| 2023-12-31 | ₩129.55 Billion | +22.14% |
| 2022-12-31 | ₩106.07 Billion | +17.74% |
| 2021-12-31 | ₩90.09 Billion | +25.21% |
| 2020-12-31 | ₩71.95 Billion | +116.52% |
| 2019-12-31 | ₩33.23 Billion | +22.00% |
| 2018-12-31 | ₩27.24 Billion | +14.64% |
| 2017-12-31 | ₩23.76 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to T&L Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 565.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩140.26 Billion | 81.82% |
| Common Stock | ₩4.46 Billion | 2.60% |
| Other Components | ₩26.71 Billion | 15.58% |
| Total Equity | ₩171.44 Billion | 100.00% |
T&L Co. Ltd Competitors by Market Cap
The table below lists competitors of T&L Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Keck Seng Malaysia Bhd
KLSE:3476
|
$153.43 Million |
|
PLAIDInc
PINK:PLDIF
|
$153.43 Million |
|
Limak Dogu Anadolu Cimento San As
IS:LMKDC
|
$153.46 Million |
|
Hana Financial 7 SPAC
KQ:230240
|
$153.52 Million |
|
IDI SCA INH. EO 710
F:8KC
|
$153.40 Million |
|
Zhejiang Benli Technology Co. Ltd.
SHE:301065
|
$153.31 Million |
|
Alkane Resources Limited
PINK:ALKEF
|
$153.29 Million |
|
Horizon Oil Limited
OTCQB:HZNFF
|
$153.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in T&L Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 129,553,114,070 to 171,436,202,680, a change of 41,883,088,610 (32.3%).
- Net income of 46,407,511,870 contributed positively to equity growth.
- Dividend payments of 4,439,606,050 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩46.41 Billion | +27.07% |
| Dividends Paid | ₩4.44 Billion | -2.59% |
| Other Changes | ₩-84.82 Million | -0.05% |
| Total Change | ₩- | 32.33% |
Book Value vs Market Value Analysis
This analysis compares T&L Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.30x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 13.14x to 2.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩3712.52 | ₩48800.00 | x |
| 2018-12-31 | ₩4255.98 | ₩48800.00 | x |
| 2019-12-31 | ₩5192.39 | ₩48800.00 | x |
| 2020-12-31 | ₩8852.28 | ₩48800.00 | x |
| 2021-12-31 | ₩11083.81 | ₩48800.00 | x |
| 2022-12-31 | ₩13140.77 | ₩48800.00 | x |
| 2023-12-31 | ₩16049.67 | ₩48800.00 | x |
| 2024-12-31 | ₩21238.35 | ₩48800.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently T&L Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 27.07%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 26.54%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.15x
- Recent ROE (27.07%) is above the historical average (20.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 20.21% | 18.06% | 0.79x | 1.41x | ₩2.43 Billion |
| 2018 | 17.10% | 17.69% | 0.72x | 1.34x | ₩1.93 Billion |
| 2019 | 21.93% | 22.34% | 0.75x | 1.30x | ₩3.96 Billion |
| 2020 | 13.96% | 24.71% | 0.51x | 1.10x | ₩2.85 Billion |
| 2021 | 21.74% | 27.24% | 0.73x | 1.09x | ₩10.58 Billion |
| 2022 | 19.91% | 25.89% | 0.70x | 1.10x | ₩10.51 Billion |
| 2023 | 21.18% | 23.76% | 0.81x | 1.10x | ₩14.48 Billion |
| 2024 | 27.07% | 26.54% | 0.89x | 1.15x | ₩29.26 Billion |
Industry Comparison
This section compares T&L Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $98,321,642,752
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| T&L Co. Ltd (340570) | ₩199.09 Billion | 20.21% | 0.10x | $153.40 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |